The essential oil maker's sales jumped 98% year-on-year, yet its net profit margin fell sharply due to higher costs and a shift in its business mix.
Quanto Agroworld's Q2 FY27 saw consolidated revenue nearly double to ₹22.31 crore, with profit up 50%. However, a significant build-up in inventory costs and a changing product mix led to a 940-basis-point drop in net profit margin.
Quanto Agroworld's second quarter was a story of explosive top-line growth meeting a sharp squeeze on profitability. The medicinal and aromatic plant specialist saw its consolidated revenue nearly double from a year ago, but the money that reached the bottom line grew at half that pace, revealing the costs of its rapid expansion.
The numbers show the split clearly. Revenue for the quarter ended September 2026 soared 97.6% year-on-year to ₹22.31 crore. Profit followed, rising a solid 49.7% to ₹6.54 crore. Yet the net profit margin contracted to 29.3%, down 940 basis points from the 38.7% margin it held in the same quarter last year.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ2 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|
| Revenue (₹ Cr) | 22.31YoY +98% | 11.29 |
| Profit (₹ Cr) | 6.54YoY +50% | 4.37 |
| Net Profit Margin (%) | 29.3YoY -24% | 38.7 |
The margin compression points directly to the cost structure of this growth. According to a scanx.trade report, a significant change in inventories, worth ₹8.09 crore, was a major component of the quarter's total expenses. This suggests the company was building stock, likely in its 'Other Products' category, which has become its largest sales stream. This inventory build, while fueling future sales, pressures margins in the near term by locking up capital and incurring holding costs.
Furthermore, the business is transforming. Data from Multibagg.ai indicates the company's 'Other Products' segment, which includes processed herbal formats, surged to become 53.9% of FY26 sales. This shift away from pure essential oil sales, coupled with the operational disruption of relocating its distillation plant last year, has altered its profitability profile. The consolidated results also received a substantial lift from its subsidiaries, Quanto Kisan and Quanto Agritech, which added roughly ₹2.41 crore to group profit beyond the parent company's earnings.
Strong revenue booking does not always mean immediate cash in hand. The scanx.trade report notes a substantial increase in trade receivables on a standalone basis, contrasting with a much smaller operating cash flow generation. This indicates a portion of the quarter's impressive sales is yet to be converted into cash, a typical growing pain for a rapidly scaling business that needs careful working capital management.
Key Points
The quarter underscores Quanto Agroworld's successful transition into a broader botanical ingredients player, evidenced by the revenue surge. However, the margin story is now more complex. The inventory-led growth and the shift in product mix suggest the high margins of its legacy essential oil business are diluting as it scales new segments.
Investors are left weighing the trade-off: robust top-line expansion against a less certain path for bottom-line efficiency. The company's plans for a fivefold expansion in essential oil capacity, as noted by Multibagg.ai, could restore margin leverage, but that depends on operational stabilisation and raw material availability. For now, the market's deep discount to the sector peers reflects this uncertainty between rapid growth and compressed returns.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.